The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis - PubMed (original) (raw)

Review

The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis

Jessica Hurtubise et al. Curr Atheroscler Rep. 2016 Dec.

Abstract

Atherosclerosis is the narrowing of arteries due to the accumulation of macrophages overloaded with lipids resulting in foam cell formation, and these events occur preferentially at the branching points of arteries which are particularly susceptible to hyperlipidemic stress-induced inflammation and oxidative stress. The different stages of atherogenesis rely on oxidative stress, endothelial dysfunction, and inflammation, and hypertension or dyslipidemia can independently trigger these stages. Dyslipidemia and hypertension are pathological conditions that damage the endothelium, triggering cell proliferation, vascular remodeling, apoptosis, and increased cellular permeability with increased adhesion molecules that bind monocytes and T lymphocytes to create a vicious cocktail of pathophysiological factors. Correspondingly, the factors are redirected by chemo-attractants and pro-inflammatory cytokines into the intima of the vasculature, where monocytes differentiate into macrophages taking up oxidized LDL uncontrollably to form foam cells and atherosclerotic lesions. Moreover, endothelial damage also causes loss of vasomotor activity, disproportionate vascular contractility, and elevation of blood pressure in dyslipidemic patients, while in hypertensive patients, further elevation of blood pressure occurs, creating a self-perpetuating vicious cycle that aggravates the development and progression of atherosclerotic lesions. This review offers an in-depth analysis of atherosclerosis and the related interplay between dyslipidemia/hypertension and critically appraises the current diagnosis, etiology, and therapeutic options.

Keywords: Dyslipidemia; Endothelial dysfunction; High-density lipoprotein; Hypertension; Inflammation; Low-density lipoprotein; Oxidative stress.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Circulation. 2003 Jun 24;107(24):3109-16 - PubMed
    1. Circulation. 2015 Feb 3;131(5):495-502 - PubMed
    1. Stroke. 1997 Jan;28(1):88-94 - PubMed
    1. Circ Res. 1983 Oct;53(4):502-14 - PubMed
    1. Hypertens Res. 2010 Apr;33(4):338-47 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources